Noblesville hits brakes on kart racing, OKs auto dealership

August 20, 2013
Back to TopCommentsE-mailPrintBookmark and Share

The Noblesville Plan Commission raised a yellow flag Monday on California-based K1 Speed Inc.’s plans for an electric go-kart racing center in the Saxony Corporate Campus.

K1 is asking for permission to transform a vacant industrial building into a high-tech indoor track, a use Plan Commission members said doesn’t seem appropriate for an area created to draw a different kind of commercial development.

“I thought the intent was [to attract] high-paying jobs,” said commission Vice President Gretchen Hanes.

Commissioners also were skeptical about K1's hours of operation and the potential impact of the operation on other Corporate Campus tenants. Members said they like to have K1 in Noblesville, but not there.

They forwarded K1’s request to the Common Council with an unfavorable (albeit nonbinding) recommendation. Council members are expected to take up the matter at their Aug. 27 meeting.

Also Monday:

— The Plan Commission signed off on plans for a 53-acre development at the southeast corner of State Roads 37 and 32 in Noblesville. Terry Lee Crossing would be anchored  by a 38,000-square-foot Hyundai dealership. Eight additional lots on the property would be available to developers if the Common Council OKs the project.

— Commissioners agreed to amend the Noblesville Parks Master Plan to add 6.4 acres of land the city is in the process of acquiring for a park on the west side of the White River downtown. With the property, the city’s parks inventory will total 840 acres.

— Carmel City Council voted 5-0 to release a $200,000 arts grant for Booth Tarkington Civic Theatre, as soon as the not-for-profit makes a scheduled $200,000 annual payment on the building it occupies in the city’s Center for the Performing Arts. The funding had been delayed since April, first because of uncertainty about the city budget and then over concerns that the theater might not fulfill its obligation.


  • It's a wash
    So pay the payment with the grant and call it a day people. How hard can this be?

Post a comment to this blog

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
  1. So, Pence wants the federal government to ignore the 2008 law that allows children from these countries to argue for asylum in front of a judge. How did this guy become governor? And how is that we'll soon be subjected to repeatedly seeing him on TV being taken seriously as a presidential candidate? Am I in Bizzaro-U.S.A.?

  2. "And the most rigorous studies of one-year preschool programs have shown short-term benefits that fade out in a few years or no benefits at all." So we are going down a path that seems to have proven not to work very well. Right intention, wrong approach?

  3. Well for Dunkin Donuts it might say that even a highly popular outlet can't make a poorly sited location work. That little strip has seen near constant churn for years.

  4. Years ago, the Pharmaceutical and Medical Device companies shifted their research investment away from Medical Institutions to focus more on private research centers, primarily because of medical institution inefficiencies in initiating clinical studies and their inability/commitment to enroll the needed number of patients in these studies. The protracted timelines of the medical institutions were prompting significant delays in the availability of new drug and medical device entities for patients and relatedly, higher R and D expenditures to the commercial industry because of these delays. While the above stated IU Health "ratio is about $2.50 in federal funding for every $1 in industry funding", the available funding is REVERSED as commercial R and D (primarily Phase I-IV clinical work)runs $2.50 to $1 for available federal funding ($76.8B to $30.9B in 2011). The above article significatly understated the available R and D funding from industry......see the Pharma and Medical Device industry websites. Clearly, if medical institutions like IU Health wish to attract more commercial studies, they will need to become more competitive with private clinical sites in their ability to be more efficient and in their commitment to meet study enrollment goals on time. Lastly, to the reference to the above Washington Post article headlined “As drug industry’s influence over research grows, so does the potential for bias", lacks some credibility as both FDA and Institutional Institutional Review Boards must approve the high proportion of these studies before studies are started. This means that both study safety and science must be approved by both entities.

  5. ChIeF and all the other critics – better is better no matter what. Get over it; they are doing better despite you ?